HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Leiner Files For Chapter 11 Protection, Explores Selling Business

This article was originally published in The Tan Sheet

Executive Summary

Leiner Health Products' shutdown of its U.S. OTC operations a year ago forced the firm to seek Chapter 11 bankruptcy protection and explore selling its U.S. business

You may also be interested in...



NBTY Anticipates Nearly 25 Percent Boost From Leiner’s Business

Supplement manufacturer NBTY expects the addition of Leiner Health Products' business will increase its annual sales by more than $500 million - nearly 25 percent

NBTY Receiving Requests To Restart Leiner’s U.S. OTC Business

Vitamin and supplement manufacturer NBTY says it has received requests to restart Leiner Health Products' U.S. private-label OTC business, but deciding whether to make the move will take up to four months

Leiner Teetered Toward Bankruptcy As FDA Investigated Testing Fraud

Whistleblowers' allegations of stability data manipulation at Leiner Health Products prompted the firm's rapid fall from a leading provider of private-label OTC drugs and dietary supplements to a property bought by a competitor in a bankruptcy court auction

Related Content

Topics

Latest News
See All
UsernamePublicRestriction

Register

RS137256

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel